---
$id: https://graph.org.ai/products/commodity/51181602
$type: Product
source: UNSPSC
code: "51181602"
title: "Liothyronine"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Liothyronine

**UNSPSC Code**: 51181602
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a generic primary tumor tnm finding with the molecular formula C15H12I3NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06LU7C9H1V, chemically known as 3,5,3-triiodothyronine but generally known as liothyronine, which bears US NIH Compound Identifier 861. European Medicines Agency schedules Liothyronine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08527MIG. The term LIOTHYRONINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). LIOTHYRONINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, LIOTHYRONINE remains the US FDA Preferred Term for this commodity. Liothyronine bears US NLM identifiers UMLS ID CL414313 and NCI Concept Code C907. SMILES: IC1CC(CC(N)C(=O)O)CC(I)C1OC1CC(I)C(O)CC1.

